Calamos Advisors’s Keen Vision Acquisition Corp Warrant KVACW Stock Holding History

Calamos Advisors’s Portfolio KVACW Stock Details KVACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3K	Hold	100,000	–	–	﹤0.01%	972
2026 Q1	$3.02K	Hold	100,000	–	–	﹤0.01%	1188
2025 Q4	$5.1K	Hold	100,000	–	–	﹤0.01%	906
2025 Q3	$6.59K	Hold	100,000	–	–	﹤0.01%	896
2025 Q2	$5.4K	Hold	100,000	–	–	﹤0.01%	894
2025 Q1	$3.21K	Hold	100,000	–	–	﹤0.01%	885
2024 Q4	$4.75K	Hold	100,000	–	–	﹤0.01%	882
2024 Q3	$5.41K	Hold	100,000	–	–	﹤0.01%	899
2024 Q2	$6.25K	Hold	100,000	–	–	﹤0.01%	901
2024 Q1	$5.39K	Buy	+100,000	New	+$4.16K	﹤0.01%	916

Other funds holding KVACW

Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return

TrueMark Investments Chicago, Illinois $798M AUM 25.52% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

Calamos Advisors's KVACW Position: Q2 2026 in Review

Calamos Advisors held its Keen Vision Acquisition Corp Warrant (KVACW) position steady in Q2 2026 at 100,000 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #972.

Calamos Advisors first reported a position in KVACW in Q1 2024 and has held it in 10 quarters since. The position peaked at $6.59K in Q3 2025. 4 funds tracked by Wall St. Rank hold KVACW as of Q2 2026.

Calamos Advisors held 100,000 shares of Keen Vision Acquisition Corp Warrant worth $3K as of Q2 2026.
Calamos Advisors left its Keen Vision Acquisition Corp Warrant share count unchanged in Q2 2026.
Keen Vision Acquisition Corp Warrant made up ﹤0.01% of Calamos Advisors's portfolio in Q2 2026, its #972 holding.
Calamos Advisors first reported a position in Keen Vision Acquisition Corp Warrant in Q1 2024 and has held it in 10 quarters since.
Calamos Advisors's Keen Vision Acquisition Corp Warrant position peaked at $6.59K in Q3 2025.
4 funds tracked by Wall St. Rank held Keen Vision Acquisition Corp Warrant as of Q2 2026.

Based on Calamos Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.